Front Row Advisors LLC
- SEC CIK
- 0001729254
- Latest filing
- Aug 13, 2026
RLMD holding history
Relmada Therapeutics, Inc. in every 13F filed by Front Row Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RLMD overviewAll 13F holders of RLMDFull Q2 2026 holdings
- Shares (Q2 2026)
- 2
- Value
- $9
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2 | $9 | <0.1% | +2 | New | Holders |
| Q1 2026 | 0 | $0 | 0.0% | −2−100.0% | Sold out | Holders |
| Q4 2025 | 2 | $10 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 2 | $4 | <0.1% | −1−33.3% | Reduced | Holders |
| Q2 2025 | 3 | $2 | <0.1% | −3−50.0% | Reduced | Holders |
| Q1 2025 | 6 | $2 | <0.1% | +6 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −6−100.0% | Sold out | Holders |
| Q3 2024 | 6 | $19 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 6 | $18 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 6 | $28 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 6 | $25 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 6 | $18 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 6 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q1 2023 | 6 | $0 | 0.0% | +6 | New | Holders |